We are live on ! Find out more
PCM

Parsifal Capital Management Portfolio holdings

AUM $826M
1-Year Est. Return 47.87%
This Fund
S&P 500
This Quarter Est. Return
+15.69%
1 Year Est. Return
+47.87%
3 Year Est. Return
+153.79%
5 Year Est. Return
+140.83%
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$145M
Cap. Flow
-$167M
Cap. Flow %
-13.67%
Top 10 Hldgs %
75.52%
Holding
22
New
6
Increased
5
Reduced
7
Closed
4

Top Buys

Rank Stock Value
1
AXTA icon
Axalta
AXTA
+$64.1M
2
VIAV icon
Viavi Solutions
VIAV
+$54.7M
3
CORZ icon
Core Scientific
CORZ
+$20.9M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.9M
5
IESC icon
IES Holdings
IESC
+$14.2M

Top Sells

Rank Stock Value
1
DLTR icon
Dollar Tree
DLTR
+$99.3M
2
ACI icon
Albertsons Companies
ACI
+$75.6M
3
AVPT icon
AvePoint
AVPT
+$65.9M
4
SXT icon
Sensient Technologies
SXT
+$46.8M
5
LPX icon
Louisiana-Pacific
LPX
+$28.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.35%
2 Healthcare 20.04%
3 Miscellaneous 18.59%
4 Industrials 16.09%
5 Technology 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SN icon
1
SharkNinja
SN
$23.5B
$134M 11.01%
1,199,937
+116,337
+11% +$11.5M
HGV icon
2
Hilton Grand Vacations
HGV
$2.97B
$111M 9.09%
2,475,501
+278,221
+13% +$11.8M
COMP icon
3
CALL
Compass
COMP
$7.91B
$107M 8.76%
+10,110,100
New +$92.2M
GMED icon
4
Globus Medical
GMED
$10.1B
$107M 8.76%
1,222,717
+118,385
+11% +$8.99M
WBD icon
5
CALL
Warner Bros
WBD
$70.1B
$96.7M 7.93%
+3,356,800
New +$78.5M
TEVA icon
6
Teva Pharmaceuticals
TEVA
$45.4B
$88M 7.22%
2,819,933
+809,426
+40% +$19.9M
GXO icon
7
GXO Logistics
GXO
$5.28B
$75.9M 6.22%
1,441,613
-41,344
-3% -$2.17M
AXTA icon
8
Axalta
AXTA
$7.1B
$70.6M 5.79%
+2,184,355
New +$64.1M
MMM icon
9
3M
MMM
$84.8B
$66.8M 5.48%
417,358
-166,500
-29% -$27.2M
ATMU icon
10
Atmus Filtration Technologies
ATMU
$3.64B
$64.1M 5.26%
1,234,287
-8,733
-0.7% -$423K
VIAV icon
11
Viavi Solutions
VIAV
$8.25B
$60.3M 4.95%
+3,385,700
New +$54.7M
AVPT icon
12
AvePoint
AVPT
$2.88B
$52.1M 4.27%
3,752,179
-4,770,561
-56% -$65.9M
UNH icon
13
UnitedHealth
UNH
$338B
$49.6M 4.07%
150,258
-4,342
-3% -$1.47M
ACI icon
14
Albertsons Companies
ACI
$6.31B
$42.4M 3.48%
2,469,593
-4,239,655
-63% -$75.6M
IESC icon
15
IES Holdings
IESC
$12.5B
$39M 3.2%
200,360
+70,760
+55% +$14.2M
Z icon
16
PUT
Zillow
Z
$7.29B
$23M 1.89%
+337,800
New +$24.5M
CORZ icon
17
Core Scientific
CORZ
$5.19B
$17.4M 1.43%
+1,197,600
New +$20.9M
LPX icon
18
Louisiana-Pacific
LPX
$4.52B
$14.6M 1.19%
180,168
-339,432
-65% -$28.7M
CVS icon
19
CVS Health
CVS
$121B
– –
-182,300
Closed -$13.7M
DLTR icon
20
Dollar Tree
DLTR
$21.4B
– –
-1,052,185
Closed -$99.3M
HUM icon
21
Humana
HUM
$47.5B
– –
-44,000
Closed -$11.4M
SXT icon
22
Sensient Technologies
SXT
$5.42B
– –
-498,500
Closed -$46.8M

Similar funds

MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return
CCMINC
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return
CIG
Cullen Investment Group Lafayette, Louisiana $827M AUM 29.64% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
AI
Arvest Investments Lowell, Arkansas $827M AUM 21.19% 1-Year Est. Return
JGUA
John G. Ullman & Associates Corning, New York $824M AUM 78.19% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
BCM
Benchstone Capital Management New York $828M AUM 50.73% 1-Year Est. Return

Parsifal Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Parsifal Capital Management held 22 positions worth $1.22B, up 13% from $1.07B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Parsifal Capital Management withdrew a net $167M in Q4 2025, closing 4 positions and reducing 7 holdings. Its most notable exit was Dollar Tree, an estimated $99.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Parsifal Capital Management opened a new position in Axalta worth $70.6M.

  • Parsifal Capital Management's largest Q4 2025 buy was Axalta: 2,184,355 shares worth $70.6M.
  • Parsifal Capital Management added most to Teva Pharmaceuticals in Q4 2025, an estimated $19.9M increase.
  • Parsifal Capital Management's biggest Q4 2025 reduction was Albertsons Companies, cutting an estimated $75.6M.
  • Parsifal Capital Management fully exited Dollar Tree in Q4 2025, selling an estimated $99.3M.
  • Parsifal Capital Management's ten largest holdings make up 76% of its $1.22B portfolio in Q4 2025.
  • Parsifal Capital Management opened 6 new positions and closed 4 in Q4 2025.
  • Parsifal Capital Management's portfolio value rose 13% quarter-over-quarter to $1.22B.

Based on Parsifal Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.